38 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
of death or disability) or (2) by the named executive officer for “good reason” (as such terms are defined in the named executive officer’s change … without cause (excluding by reason of death or disability) or (2) by the named executive officer for good reason, the named executive officer
8-K
EX-10.1
ATHA
Athira Pharma Inc
22 Feb 24
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
4:10pm
promulgated under the Securities Act.
2.12“Director” means a member of the Board.
2.13“Disability” means total and permanent disability as defined … in Code Section 22(e)(3), provided that the Administrator in its discretion may determine whether a permanent and total disability exists in accordance
8-K
EX-10.1
ATHA
Athira Pharma Inc
8 Jan 24
Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update
7:11am
immediately and without prior notice for Cause or due to Service Provider’s death or Disability. A termination shall be for “Cause” if it is for any … , of the Company. “Disability” means inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment
8-K
EX-10.2
ATHA
Athira Pharma Inc
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
, and Arbitration Agreement entered into with the Company dated May 18, 2023.
7.8. “Director” means a member of the Board.
7.9. “Disability” means … total and permanent disability as defined in Code Section 22(e)(3).
7.10. “Good Reason” means Executive’s termination of Executive’s employment
8-K
4tr14pfh43836gq
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
8-K
EX-10.3
xygrsnf5wch265a9m
22 May 23
Athira Pharma Appoints Andrew Gengos as Chief Financial Officer and Chief Business Officer
8:00am
DEFC14A
6pjht
5 Apr 22
Proxy in contested solicitation
4:08pm
PREC14A
b5i73ythwzsqfusoftop
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
EX-10.1
1yqzknt4mr1xhycfnjts
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
8-K
2fmguv oiz30xm1ayy
31 Jan 22
Athira Pharma Announces Appointment of Grant Pickering to its Board of Directors
4:15pm
8-K
lwa4cy
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-10.1
6b86rzf84 ta3
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
fvt0jk0v
17 Jun 21
Departure of Directors or Certain Officers
9:32pm
DEF 14A
9iyjo41efb0iwwjj
16 Apr 21
Definitive proxy
6:02am